Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASBP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ASBP
Aspire Biopharma Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASBP
Aspire Biopharma Holdings, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ASBP
0
None
Shared
0
No disclosed counterparties: ASBP.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
ASBP
Aspire Biopharma Holdings, Inc.
Change
7.30
▼
−0.14%
· post 7.30
Mkt cap
$10.3M
Revenue
$20,732
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
ASBP
Aspire Biopharma Holdings, Inc.
vs
LLY
ELI Lilly & Co
7.30
▼
−0.14%
post 7.30
Price
1,371.32
▼
−3.29%
post 1,363.77
$10.3M
Mkt cap
$1.3T
Q2 FY26
$20,732
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ASBP
7.30
▼
−0.14%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26